THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

FDA orders fixes at hip implant firm

Email|Print| Text size + By
Associated Press / January 17, 2008

TRENTON, N.J. - Federal regulators have ordered medical device maker Stryker Corp. to fix a host of longstanding problems in its manufacturing of hip replacement parts that have triggered multiple patient complaints and forced some follow-up surgeries.

The Food and Drug Administration told Kalamazoo, Mich.-based Stryker in a letter that it was aware the company has received patient complaints since January 2005 about problems, including fit of implants that caused bone fractures. Patients also have complained about pain, difficulty walking, and "squeaky" joints.

The letter was prepared after FDA officials spent six weeks last summer inspecting the company's orthopedics division headquarters in Mahwah, N.J., which houses manufacturing operations.

A statement from Stryker said: "We take these matters very seriously and are committed to developing, manufacturing, and marketing medical products that are safe and effective and that comply with applicable laws and regulations."

more stories like this

  • Email
  • Email
  • Print
  • Print
  • Single page
  • Single page
  • Reprints
  • Reprints
  • Share
  • Share
  • Comment
  • Comment
 
  • Share on DiggShare on Digg
  • Tag with Del.icio.us Save this article
  • powered by Del.icio.us
Your Name Your e-mail address (for return address purposes) E-mail address of recipients (separate multiple addresses with commas) Name and both e-mail fields are required.
Message (optional)
Disclaimer: Boston.com does not share this information or keep it permanently, as it is for the sole purpose of sending this one time e-mail.